Home Management of gestational hypertension – the impact of HYPITATa
Article
Licensed
Unlicensed Requires Authentication

Management of gestational hypertension – the impact of HYPITATa

  • Jaimey M. Pauli EMAIL logo , Julianne R. Lauring , Christy M. Stetter , John T. Repke , John J. Botti , Serdar H. Ural and Anthony Ambrose
Published/Copyright: February 11, 2013
Journal of Perinatal Medicine
From the journal Journal of Perinatal Medicine Volume 41 Issue 4

Abstract

Aims: The objective of this study was to examine the impact of one trial (the HYPITAT trial) on management of gestational hypertension.

Study design: This is a retrospective cohort study of 5077 patients delivered at our institution from 7/1/2008 to 6/15/2011. “Pre-HYPITAT” was defined as 7/1/2008–9/30/2009 and “Post-HYPITAT” as 10/1/2009–6/15/2011. The primary outcome is the rate of delivery intervention for gestational hypertension. Secondary maternal and neonatal outcomes were analyzed in patients with gestational hypertension only. Statistical analyses included the χ2-test, Fisher’s exact test, and the two-sample t-test.

Results: The rate of delivery intervention Pre-HYPITAT was 1.9%, compared to 4% Post-HYPITAT (P<0.001). There was no significant change in secondary outcomes.

Conclusion: There was a statistically significant increase in delivery intervention for gestational hypertension at our institution after the publication of the HYPITAT trial. There was no significant change in immediate maternal or neonatal outcomes for patients with gestational hypertension.

Keywords: Gestational hypertension; hypertension in pregnancy; pregnancy-induced hypertension
Corresponding author: Jaimey M. Pauli, MD, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Drive, H103 Hershey, PA 17033, USA, Tel.: +1 717 5318142x5, Fax: +1 717 5310117
  1. a

    Poster presented at The Society for Maternal-Fetal Medicine 32nd Annual Meeting, Dallas, TX, USA, February 6–12, 2012.

References

[1] Ferrazzani S, Luciano R, Garofalo S, D’Andrea V, De Carolis S, De Carolis MP, et al. Neonatal outcome in hypertensive disorders of pregnancy. Early Hum Dev. 2011;87:445–9.10.1016/j.earlhumdev.2011.03.005Search in Google Scholar

[2] Gofton EN, Capewell V, Natale R, Gratton RJ. Obstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertension. Am J Obstet Gynecol. 2001;185:798–803.10.1067/mob.2001.117314Search in Google Scholar

[3] Habli M, Levine RJ, Qian C, Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol. 2007;197: 406.e1–7.10.1016/j.ajog.2007.06.059Search in Google Scholar

[4] Koopmans CM, Bijlenga D, Aarnoudse JG, van Beek E, Bekedam DJ, van den Berg PP, et al. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. BMC Pregnancy Childbirth. 2007;7:14.10.1186/1471-2393-7-14Search in Google Scholar

[5] Koopmans CM, Bijlenga D, Groen H, Vijigen SMC, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.10.1016/S0140-6736(09)60736-4Search in Google Scholar

[6] Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild preeclampsia between 34 and 37 weeks gestation (HYPITAT II): a multi-centre, open-label randomized controlled trial. BMC Pregnancy Childbirth. 2011;11:50.10.1186/1471-2393-11-50Search in Google Scholar PubMed PubMed Central

[7] Menacker F, Hamilton BE. Recent trends in cesarean delivery in the United States. NCHS Brief No. 35, March 2010.10.1037/e665412010-001Search in Google Scholar

[8] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–22.10.1067/mob.2000.107928Search in Google Scholar

[9] Roberts JM, Funai EF. Pregnancy-related hypertension. In: Creasy RK, Resnik R, Iams JD, editors. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 6th ed. Philadelphia (PA): Saunders; 2009. pp. 651–88.10.1016/B978-1-4160-4224-2.50038-7Search in Google Scholar

[10] Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become preeclampsia? Br J Obstet Gynaecol. 1998;105:1177–84.10.1111/j.1471-0528.1998.tb09971.xSearch in Google Scholar PubMed

[11] Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–93.Search in Google Scholar

[12] van der Tuuk K, Koopmans C, Groen H, Mol B, van Pampus M for the HYPITAT study group. Impact of the HYPITAT trial on doctors’ behavior and prevalence of eclampsia in the Netherlands. Br J Obstet Gynaecol. 2011;118:1658–60.10.1111/j.1471-0528.2011.03138.xSearch in Google Scholar PubMed

[13] Xiong X, Demianczuk NN, Sauders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol. 2002;155:203–9.10.1093/aje/155.3.203Search in Google Scholar PubMed

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2012-8-2
Accepted: 2013-1-4
Published Online: 2013-02-11
Published in Print: 2013-07-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Anxious and depressive components of Edinburgh Postnatal Depression Scale in maternal postpartum psychological problems1)
  5. Original Articles – Obstetrics
  6. Isolated low-normal amniotic fluid volume in the early third trimester: association with adverse perinatal outcomesa
  7. Trends in twin pregnancies and mode of delivery during the last 30 years: inconsistency between guidelines and clinical practice
  8. Prenatal care in adult women exposed to childhood sexual abuse
  9. Maternal and fetal adropin levels in gestational diabetes mellitus
  10. Ethnic disparities in perinatal mortality at 40 and 41 weeks of gestation
  11. Polymorphisms in the activin A receptor type 2A gene affect the onset time and severity of preeclampsia in the Turkish population
  12. Outcome of isolated fetal renal pyelectasis diagnosed during midtrimester screening ultrasound and cut-off value to predict a persistent or progressive pyelectasis in utero
  13. A polymorphism in an autophagy-related gene, ATG16L1, influences time to delivery in women with an unfavorable cervix who require labor induction
  14. Management of gestational hypertension – the impact of HYPITATa
  15. Reliability of quantitative elastography of the uterine cervix in at-term pregnancies
  16. Congenital anomalies, prematurity, and low birth weight rates in relation to nuclear power plant proximity1)
  17. Original Articles – Fetus
  18. Fetal magnetic resonance imaging of lymphangiomas
  19. Original Articles – Newborn
  20. Brainstem dysgenesis during the neonatal period: diagnosis and management
  21. Improving admission temperature in extremely low birth weight infants: a hospital-based multi-intervention quality improvement project
  22. Short Communication
  23. Periconceptional use of folic acid and risk of miscarriage – findings of the Oral Cleft Prevention Program in Brazil
  24. Congress Calendar
  25. Congress Calendar
https://doi.org/10.1515/jpm-2012-0179
Keywords for this article
Gestational hypertension; hypertension in pregnancy; pregnancy-induced hypertension

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Anxious and depressive components of Edinburgh Postnatal Depression Scale in maternal postpartum psychological problems1)
  5. Original Articles – Obstetrics
  6. Isolated low-normal amniotic fluid volume in the early third trimester: association with adverse perinatal outcomesa
  7. Trends in twin pregnancies and mode of delivery during the last 30 years: inconsistency between guidelines and clinical practice
  8. Prenatal care in adult women exposed to childhood sexual abuse
  9. Maternal and fetal adropin levels in gestational diabetes mellitus
  10. Ethnic disparities in perinatal mortality at 40 and 41 weeks of gestation
  11. Polymorphisms in the activin A receptor type 2A gene affect the onset time and severity of preeclampsia in the Turkish population
  12. Outcome of isolated fetal renal pyelectasis diagnosed during midtrimester screening ultrasound and cut-off value to predict a persistent or progressive pyelectasis in utero
  13. A polymorphism in an autophagy-related gene, ATG16L1, influences time to delivery in women with an unfavorable cervix who require labor induction
  14. Management of gestational hypertension – the impact of HYPITATa
  15. Reliability of quantitative elastography of the uterine cervix in at-term pregnancies
  16. Congenital anomalies, prematurity, and low birth weight rates in relation to nuclear power plant proximity1)
  17. Original Articles – Fetus
  18. Fetal magnetic resonance imaging of lymphangiomas
  19. Original Articles – Newborn
  20. Brainstem dysgenesis during the neonatal period: diagnosis and management
  21. Improving admission temperature in extremely low birth weight infants: a hospital-based multi-intervention quality improvement project
  22. Short Communication
  23. Periconceptional use of folic acid and risk of miscarriage – findings of the Oral Cleft Prevention Program in Brazil
  24. Congress Calendar
  25. Congress Calendar
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 27.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2012-0179/html
Scroll to top button